- Lilly and Novo Nordisk are competing in the weight loss drug market, with Lilly expanding its US market coverage.
- Eli Lilly and Novo Nordisk have both developed anti-obesity drugs, intensifying competition in the weight loss market.
- Eli Lilly raised Zepbound prices in the U.K. and plans to follow price hikes across Europe, while Novo Nordisk received a drug price reduction letter amid Trump administration pressure.
- The FDA has ruled on copycat drugs produced in China, while Novo Nordisk navigates price reduction demands from Trump and leadership changes.
Trump administration announced FDA coverage changes regarding Chinese suppliers who are not registered.
2 reports, 2 independent
Updated Jul 17
Gone quiet
- Reports
- 2
- Developments
- 6
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Trump administration announced FDA coverage changes regarding Chinese suppliers who are not registered.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- The Trump administration is leading to FDA job cuts, while Elon Musk spearheaded the Department of Government Efficiency, and China has surpassed the US in clinical trial volume.Sub-event
- The FTC is scrutinizing companies for Chinese sourcing claims amid concerns over unlawful Chinese vapes flooding the US.Sub-event
Trump alleges China stole U.S. voter data; FDA approval relies on international standards.1 source
- Ingredients sourced from China are facing compliance issues due to new tariffs and required ingredient and labeling changes to meet FDA standards.Sub-event
- The FDA is currently evaluating data needed for alternate dosing licenses, while sales in China declined significantly in 2025.Sub-event
Trump administration announced FDA coverage changes concerning unregistered Chinese suppliers.1 source
Keep exploring
The entities involved
- FDA
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
-
China
cultural region, ancient civilization, and nation in East Asia; mostly refers to the People's Republic of China in political situation and rarely refers to the Republic of China
Related events
- The US administration rejected a proposed FDA-style central AI regulator while acknowledging the need to compete with China in the AI race.
- FDA clearance drives market expansion and coverage for NeurAxis, Inc.
- Fox News reports on agency actions and challenges as the FDA nominee faces confirmation hearing pressure.
Coverage
Newest first; wire copies grouped- forbes.com
- BenzingaAmericans Are Turning To DIY Weight Loss Injections to Dodge $1,000+ Monthly Drug Costs Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limi